1. Introduction {#s0005}
===============

Primitive neuroectodermal tumors (PNETs) are rare neoplasms that can occur in the female genital tract, among other visceral sites. The most common location within the female genital tract is the ovary, followed by the uterine corpus ([@bb0005]), vagina, and cervix ([@bb0010]).

PNETs can present in pure form or admixed with other components, including endometrioid adenocarcinoma, adenosarcoma, carcinosarcoma (metaplastic carcinoma), and heterologous sarcomas ([@bb0015], [@bb0020]). When considering PNET as a diagnosis, the differential should include poorly-differentiated endometrioid carcinoma, non-keratinized squamous cell carcinoma, endometrial stromal sarcoma, lymphoma, small cell neuroendocrine carcinoma, and metastasis.

To date, over 58 cases of uterine PNETs have been published in the literature, the largest being a seventeen-patient case series by [@bb0005]. While these cases share the same diagnosis, they vary in their presentation, management, and outcomes ([Table 1](#t0005){ref-type="table"}). We report an additional case of cPNETs of the uterine corpus, with this being the first case treated with surgical debulking and adjuvant cisplatin, etoposide and bevacizumab, with no evidence of disease recurrence forty-eight months following intervention.

2. Case report {#s0010}
==============

A 26 year-old nulligravid, Hispanic female presented to an outside institution with dysfunctional uterine bleeding for four months. She was treated with oral contraceptives without resolution of her symptoms. A transvaginal ultrasound was performed, which showed an enlarged uterus with a 5.7 × 7 × 7 cm homogenous mass located within the lower uterine segment, as well as an enlarged right ovary. An endometrial biopsy showed endometrial tissue with possible small cell neuroectodermal tumor. The patient was then referred to our institution where a repeat endometrial biopsy showed high-grade malignant tumor infiltrating cervical tissue, favoring PNETs. A computed tomography (CT) study demonstrated a large uterus measuring up to 8.2 cm in width with a 5.8 × 4.2 cm mass within the myometrium, a 4.1 cm cystic lesion in the right adnexa, ascites, a left-sided pleural effusion, and mildly enlarged para-aortic lymph nodes. Dilatation and curettage were performed, and pathologic examination revealed a high grade malignant tumor, favoring PNETs. The patient then underwent an exploratory laparotomy with radical tumor debulking, total abdominal hysterectomy with pelvic lymphadenectomy, bilateral salpingo-oophorectomy, omentectomy, and removal of tumor from the posterior cul-de-sac. Intra-operative findings were consistent with stage IV uterine cancer. Although the patient was optimally surgically debulked, there was still residual tumor measuring less than 1 cm at the conclusion of the procedure.

2.1. Pathology {#s0015}
--------------

On gross examination, the uterus contained an exophytic 7.1 × 6.0 × 2.6 cm white-tan marbled mass with areas of hemorrhage and necrosis, occupying the entirety of the endometrial cavity, and infiltrating the full thickness of the myometrium (2.6 cm). In addition, the mass involved both right (7.1 × 5.5 × 2.5 cm) and left ovaries (4.8 × 2.6 × 2.4 cm), with extension from the fallopian tubes. Hematoxylin and eosin microscopic examination showed a proliferation of sheets and nests of cells with round to oval hyperchromatic nuclei, finely granular chromatin, conspicuous multiple nucleoli, and scant cytoplasm. Homer-Wright rosettes and pseudo-rosettes were frequently observed ([Fig. 1](#f0005){ref-type="fig"}a). Widespread lymphovascular invasion was present, and mitotic figures were common (48/10 high power fields). Immunohistochemical stains demonstrated that the tumor cells were negative for CK 8/18, CK AE1/3, CD10, CD34, desmin, MSA, Myf-4, GFAP, chromogranin, neurofilament, CD99 and FLI1. Positive stains included vimentin, CD56, NSE, and synaptophysin ([Fig. 1](#f0005){ref-type="fig"}b--c). Antibodies against vascular endothelial growth factor (VEGF) (VG1 clone, Novus) showed positive cytoplasmic staining ([Fig. 1](#f0005){ref-type="fig"}d). In addition, CD34 and MSA highlighted a prominent network of endothelial cells within the sheets and nests of small hyperchromatic cells ([Fig. 1](#f0005){ref-type="fig"}e--f). Fluorescence in situ hybridization (FISH) analysis using a LSI EWSR1 dual color, break-apart probe (Abbot Molecular) revealed no evidence of EWSR1 gene rearrangement.

2.2. Treatment {#s0020}
--------------

Following discussion of the patient\'s case at our institution\'s gynecologic oncology tumor board, the decision was made to treat the patient with six cycles of cisplatin and etoposide. Bevacizumab was added to the regimen for the second through sixth cycles given the finding of ascites. Response to treatment was followed with physical examination, serial CA-125 levels, and CT scans of the chest, abdomen and pelvis.

Baseline CA-125 was 372 U/mL. CA-125 levels obtained prior to administration of the second through sixth cycles were 189 U/mL, 31 U/mL, 22 U/mL, 15 U/mL, and 15 U/mL respectively. Three months following the last cycle, the CA-125 level was 12 U/mL. Her most recent CA-125 was 10 U/mL, sixty-one months post-treatment.

A CT scan following the third cycle of cisplatin/etoposide/bevacizumab showed resolution of ascites and pleural effusion with mildly enlarged retroperitoneal lymph nodes. Three months after completion of chemotherapy, imaging showed stability of the retroperitoneal lymph nodes without evidence of disease. Her most recent scan, performed forty-eight months after completion of therapy, shows no evidence of recurrence.

2.3. Toxicity {#s0025}
-------------

The patient tolerated the chemotherapy with resultant Eastern Cooperative Oncology Group (ECOG) Grade 3 nausea and vomiting which required hospitalization three times for IV hydration and IV antiemetics. Because of ECOG Grade 3 neutropenia, she was given pegfilgrastim on day 3 of each subsequent cycle. Given the patient\'s response to the chemotherapy regimen of cisplatin/etoposide/bevacizumab in treating her stage IV endometrial primitive neuroectodermal tumor, the patient was placed on surveillance. At sixty-two months following treatment, the patient is disease-free based on tumor markers, physical examination, and CT imaging studies.

3. Discussion {#s0030}
=============

PNETs are small round cell tumors with glial, neural, and ependymal differentiation, thought to be derived from fetal neuroectodermal tissue ([@bb0025]). PNETs can be further classified based on degree of differentiation, location and genetic signatures into peripheral and central types. Peripheral-type PNET/Ewing sarcoma (pPNET/ES) is believed to originate from neural crest and occur outside of the central nervous system. Immunohistochemically, the great majority of pPNET/ES demonstrate CD99 and FLI1 positivity, and cytogenetics demonstrate the characteristic t(11;22)(q24;q12) translocation and *EWSR1*/*FLI1* gene fusion ([@bb0015], [@bb0030]). cPNET/neuroblastoma are derived from the central neuraxis and involve central structures including the brain and spinal cord, and generally lack the EWSR1 gene rearrangement ([@bb0025]). The majority of primary uterine PNETs lack the EWSR1 gene translocation, as in our case, and therefore resemble a cPNET.

Uterine PNETs are rare tumors that typically present in postmenopausal women although a minority present in the second decade, highlighting a bimodal age distribution. Abnormal uterine bleeding is the most common presenting symptom, and a uterine mass the most common finding on exam. Uterine PNETs are frequently diagnosed at an advanced stage, highlighting their aggressive nature. The two-year survival of younger patients and postmenopausal patients has been reported as 75% and 32%, respectively ([@bb0035]). Factors that portend a poor prognosis for the PNET family of tumors include metastatic disease at presentation (as confirmed by imaging, as well as cytologic and histologic examination of the bone marrow), primary extraosseous tumor, central or pelvic disease, age at diagnosis of 26 or older, tumor size greater than 8 cm, poor response to chemotherapy, absence of EWS-FLI1 fusion gene, and elevated pretreatment LDH ([@bb0040], [@bb0045]).

There is no consensus regarding the optimal treatment of uterine PNETs. Patients treated with surgery and radiation have a relapse rate approaching 90% ([@bb0050]). Multimodal therapy improves disease free survival, but the optimal chemotherapeutic regimen has not yet been demonstrated ([@bb0055]). Our patient underwent surgical management with optimal debulking as defined by measurable disease less than 1 cm followed by adjuvant chemotherapy alone. We chose to treat this patient with cisplatin and etoposide. Because the patient exhibited a large amount of ascites intraoperatively, as well as pleural effusion on post-operative imaging, the decision was made to add bevacizumab, a humanized monoclonal antibody directed against VEGF, to this regimen. VEGF has been implicated as a stimulator of vascular permeability, a contributing factor to malignant ascites ([@bb0060]). Because she did not exhibit any evidence of disease following chemotherapy, she did not receive post-operative radiation.

Due to the rare nature of uterine PNET and few case reports in the literature, it is difficult to determine the optimal course of treatment. Because cases of PNET are so rare, it is also problematic to accurately predict rates of survival or recurrence of this particular type of malignant neoplasm. To date there have been no case reports in the literature using the combination of cisplatin/etoposide/bevacizumab for adjuvant treatment of uterine PNET. Bevacizumab has been previously shown to be a potential therapeutic modality in vitro ([@bb0065]), and a case series exploring its therapeutic value in the management of recurrent medulloblastoma have yielded objective response rates ([@bb0070]). Oberstein et al. reviewed three phase II clinical trials employing bevacizumab in the management of pancreatic neuroendocrine carcinomas, including PNET, showing a partial response rate ranging from 0 to 56% and mean progression-free survival ranging from 4.2 months to 23.7 months ([@bb0075]).

The presence of neoplastic endothelial proliferation and VEGF positivity within the tumor provides a rational explanation to the effectiveness of this novel chemotherapy modality against uterine cPNET. This treatment option was tolerated by our patient with the side effects of Grade 3 nausea, which was supported with hospitalization and administration of IV fluids and antiemetics, and Grade 3 neutropenia, which was improved by the addition of pegfilgrastim and supportive care. Based on our patient\'s histopathologic and immunohistochemical features of this particular cPNET, and the favorable response to treatment using cisplatin/etoposide/bevacizumab, prospective clinical trials are required to evaluate the efficacy of this treatment schema in the management of advanced-stage uterine cPNET.
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###### 

Clinical characteristics, surgical management, adjuvant chemotherapy, and follow-up of reported cases of uterine PNET.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                        Age   Initial sign/symptom                               FIGO stage      Surgery                                                        Chemotherapy                                         Follow-up
  ----------------------------- ----- -------------------------------------------------- --------------- -------------------------------------------------------------- ---------------------------------------------------- -------------------------------------------------
  [@bb0020]                     58    Vaginal bleeding, abdominal pain, weight loss      IV              TAH, BSO, segmental enterectomy, total colectomy, right PLND   Carboplatin\                                         Died, 11 months with sepsis from pyelonephritis
                                                                                                                                                                        Paclitaxel                                           

  Celik et al.                  32    Abdominal pain, pelvic mass                        IIIA            TAH, BSO, PLND, PALND, omentectomy, appendectomy               Cisplatin\                                           NED, 38 months
                                                                                                                                                                        Ifosfamide\                                          
                                                                                                                                                                        Adriamycin\                                          
                                                                                                                                                                        Vincristine\                                         
                                                                                                                                                                        (PIAV)                                               

  Bhardwaj et al.               50    Vaginal bleeding, pelvic mass                      IIIC            TAH, BSO, omentectomy, PLND                                    Unknown chemotherapy regimen                         NED, 6 months

  [@bb0035]                     66    Vaginal bleeding                                   I               TAH, BSO, omentectomy, PLND, PALND                             Not done                                             NED, 2 years

  [@bb0035]                     65    Vaginal bleeding                                   IIIC            TAH, BSO, omentectomy, PLND, PALND, upper vaginectomy          Cisplatin\                                           Lung metastasis, 3 months\
                                                                                                                                                                        Doxorubicin\                                         AWD, 12 months
                                                                                                                                                                        Etoposide\                                           
                                                                                                                                                                        Paclitaxel                                           

  Karseladze et al.             16    Vaginal bleeding                                   I               TAH, BSO, omentectomy                                          Vincristine\                                         NED, 4 years
                                                                                                                                                                        Cyclophosphamide\                                    
                                                                                                                                                                        Doxorubicin                                          

  Hendrickson and Scheithauer   12    Vaginal bleeding, pelvic mass                      IVB             TAH, LSO                                                       Cyclophosphamide\                                    Pelvic recurrence, 12 months\
                                                                                                                                                                        Doxorubicin\                                         DOD, 2 years
                                                                                                                                                                        Vincristine                                          

  Hendrickson and Scheithauer   57    Vaginal bleeding, uterine mass                     IIB             TAH, BSO, PALND                                                Cisplatin\                                           Lung metastasis, 5 months\
                                                                                                                                                                        Vinblastine\                                         DOD, 2 years
                                                                                                                                                                        Bleomycin                                            

  Rose et al.\                  17    Vaginal bleeding, pelvic mass                      IIIC            RH, PLND, bilateral ovarian wedge biopsy                       Vincristine\                                         NED, \> 10 years
  Ward et al.                                                                                                                                                           Cisplatin\                                           
                                                                                                                                                                        Doxorubicin\                                         
                                                                                                                                                                        Dactinomycin\                                        
                                                                                                                                                                        Cyclophosphamide\                                    
                                                                                                                                                                        Etoposide                                            

  Daya et al.                   67    Vaginal bleeding, enlarged uterus                  IIIC            SCH, BSO                                                       Cisplatin\                                           Persistent\
                                                                                                                                                                        Doxorubicin\                                         DOD, 6 months
                                                                                                                                                                        Carboplatin\                                         
                                                                                                                                                                        5-FU                                                 

  Daya et al.                   68    Vaginal bleeding, enlarged uterus                  IVB             TAH, BSO, PLND                                                 Cisplatin                                            Persistent\
                                                                                                                                                                                                                             DOD, 12 months

  Daya et al.                   69    Vaginal bleeding                                   I               TAH, BSO, PLND                                                 Not done                                             NED, 6 years

  Daya et al.                   68    Vaginal bleeding                                   I               TAH, BSO                                                       Not done                                             NED, 5 years

  Molyneux et al.               72    Vaginal bleeding                                   I               TAH, BSO                                                       Not done                                             DOD, 8 months

  Fragetta et al.               78    Vaginal bleeding                                   IB              TAH, BSO, PLND                                                 Not done                                             NED, 9 months

  Sorenson et al.               62    Vaginal bleeding                                   I               TAH, BSO                                                       Vincristine\                                         DOD, 18 months
                                                                                                                                                                        Cyclophosphamide\                                    
                                                                                                                                                                        Cisplatin                                            

  Taieb et al.                  36    Uterine enlargement                                I               RH, BSO, PLND                                                  Not done                                             NR

  Ng et al.                     48    Vaginal bleeding                                   IIIC            TAH, BSO                                                       Not done                                             

  [@bb0050]                     26    Pelvic mass noted at cesarean section              III             RH, PLND, bilateral ovarian transposition                      Vincristine\                                         NED, 16 months
                                                                                                                                                                        Doxorubicin\                                         
                                                                                                                                                                        Cyclophosphamide\                                    
                                                                                                                                                                        Etoposide                                            

  [@bb0040]                     24    Fever, abdominal pain, pelvic mass                 II              TAH, BSO, omentectomy                                          Vincristine\                                         Recurrence, 1 months
                                                                                                                                                                        Doxorubicin\                                         
                                                                                                                                                                        Cyclophosphamide\                                    
                                                                                                                                                                        Ifosfamide\                                          
                                                                                                                                                                        Etoposide                                            

  Akbayir et al.                22    Vaginal bleeding, adnexal mass                     I               TAH, BSO, PLND, PALND, omentectomy                             Cisplatin\                                           NED, 10 months
                                                                                                                                                                        Doxorubicin                                          

  Peres et al.                  15    Abdominal pain, fever, pelvic mass                 I               TAH, PLND                                                      Carboplatin\                                         NED, 12 months
                                                                                                                                                                        Etoposide                                            

  [@bb0030]                     43    Vaginal bleeding, uterine enlargement              IIIC            TAH, BSO, PLND                                                 Cytoxan\                                             NED, 2 months
                                                                                                                                                                        Adriamycin\                                          
                                                                                                                                                                        Vincristine\                                         
                                                                                                                                                                        Etoposide                                            

  Park et al.                   30    Vaginal bleeding, uterine enlargement              IVB             None                                                           Vincristine\                                         DOD, 16 months
                                                                                                                                                                        Doxorubicin\                                         
                                                                                                                                                                        Ifosfamide\                                          
                                                                                                                                                                        Carboplatin\                                         
                                                                                                                                                                        Etoposide                                            

  [@bb0055]                     59    Vaginal bleeding, pelvic mass                      IIIC            TAH, BSO, PLND, PALND, omentectomy                             Paclitaxel\                                          AWD, 12 months
                                                                                                                                                                        Carboplatin                                          

  Majeed et al.                 27    Vaginal bleeding, uterine mass                     NR              TAH/BSO                                                        Vincristine +\                                       NED, 2 years
                                                                                                                                                                         Etoposide +\                                        
                                                                                                                                                                         Doxorubicin +\                                      
                                                                                                                                                                         Ifosfamide/\                                        
                                                                                                                                                                        Vincristine +\                                       
                                                                                                                                                                         Ifosfamide                                          

  Ren et al.                    56    Vaginal bleeding                                   IB              TAH, BSO, PLND                                                 Ifosfamide\                                          NED, 41 months
                                                                                                                                                                        Etoposide\                                           
                                                                                                                                                                        Cisplatin                                            

  Fukunaga et al.               54    Unknown                                            NR              TAH, BSO                                                       Cyclophosphamide\                                    AWD, 3 months
                                                                                                                                                                        Cisplatin\                                           
                                                                                                                                                                        Doxorubicin\                                         
                                                                                                                                                                        5-FU                                                 

  Venizelos et al.              68    Vaginal bleeding                                   I               TAH, BSO                                                       Not done                                             NED, 10 months

  [@bb0005]                     58    Vaginal bleeding with palpable mass                IIIC            Unknown surgery                                                Not done                                             DOD, 2 months

  [@bb0005]                     31    Back pain from metastatic disease                  IV              Not done                                                       Unknown chemotherapy regimen                         DOD, 20 months

  [@bb0005]                     72    Vaginal bleeding                                   IA              Unknown                                                        Unknown                                              DOD, 11 months

  [@bb0005]                     48    Unknown                                            IIIC            Unknown                                                        Unknown                                              Unknown

  [@bb0005]                     81    Vaginal bleeding                                   Unknown         Unknown                                                        Unknown                                              Unknown

  [@bb0005]                     66    Pelvic mass                                        IIIC            Unknown surgery                                                Letrozole                                            NED, 41 months

  [@bb0005]                     53    Vaginal bleeding                                   Unknown         Unknown                                                        Unknown                                              DOD, 22 months

  [@bb0005]                     51    Vaginal bleeding                                   Unknown         Unknown                                                        Unknown                                              DOD, 12 months

  [@bb0005]                     31    Vaginal bleeding                                   Unknown         Unknown                                                        Unknown                                              DOD, 26 months

  [@bb0005]                     64    Cervical polyp                                     IIB/\           TAH, BSO                                                       Unknown chemotherapy regimen                         NED, 36 months
                                                                                         possible IIIC                                                                                                                       

  [@bb0005]                     64    Vaginal bleeding with pain                         Unknown         Unknown                                                        Unknown                                              Unknown

  [@bb0005]                     69    Vaginal bleeding                                   IV by imaging   Unknown                                                        Unknown                                              Unknown

  [@bb0005]                     62    Uterine fibroids                                   IIIC            Unknown                                                        Unknown                                              DOD, 22 months

  [@bb0005]                     55    Vaginal bleeding with fibroids                     IB              TAH, BSO                                                       Unknown chemotherapy regimen                         NED, 38 months

  [@bb0005]                     52    Unknown                                            IV              Unknown                                                        Unknown                                              NED, 6 months

  [@bb0005]                     58    Vaginal pressure with passage of tissue            IV              Not done                                                       Unknown chemotherapy regimen                         NED, 6 months

  [@bb0005]                     57    Unknown                                            IIIC            Not done                                                       Unknown chemotherapy regimen                         NED, 35 months

  Stolnicu et al.               12    Vaginal bleeding with passage of tissue            Unknown         Not done                                                       Etoposide, Bleomycin, Cisplatin                      NED, 36 months

  Vignali et al.                31    Vaginal bleeding, intermittent abdominal pain      IIIC            Unknown                                                        Cisplatin, Etoposide                                 NED, 24 months

  Cate et al.                   25    Vaginal bleeding, uterine inversion and prolapse   Unknown         TAH                                                            Not done                                             NED, 18 months

  Dizon et al.                  50    Abdominopelvic pain                                Unknown         TAH, BSO, omentectomy,                                         Carboplatin, Etoposide                               NED, 16 months

  Shimada et al.                63    Constipation                                       Unknown         TAH, BSO                                                       Cyclophosphamide, Vincristine, Adriamycin            NED, 24 months

  Yi et al.                     29    Abdominal swelling and pain                        IVB             TAH, BSO, PALND, PLND, omentectomy                             Neoadjuvant docetaxel and carboplatin.\              AWD, 18 months\
                                                                                                                                                                        Vincristine, Adriamycin, Cyclophosphamide            Liver metastasis

  Aminimoghaddam et al.         32    Vaginal bleeding, abdominal pain                                   TAH, BSO, PLND                                                 Holoxan, Mesna, Cisplatin, Paclitaxol, Carboplatin   AWD, unknown

  Current case                  26    Vaginal bleeding, uterine mass                     IV              TAH, BSO, omentectomy, PLND                                    Carboplatin\                                         NED, 48 months
                                                                                                                                                                        Etoposide\                                           
                                                                                                                                                                        Avastin                                              
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

TAH, total abdominal hysterectomy; LSO, left salpingo-oophorectomy; DOD, died of disease; BSO, bilateral salpingo-oophorectomy; PALND; pelvic and para-aortic lymph node dissection; RH, radical hysterectomy; PLND, pelvic lymph node dissection; NED, no evidence of disease; SCH, supracervical hysterectomy; AWD, alive with disease; NR, not recorded.
